RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE CURRENT STATE OF PLAY

Multiple myeloma (MM) usually responds to treatment but is incurable. The clinical course is characterised, in most patients, by a series of remissions and relapses. For younger patients, the initial treatment currently usually involves induction with the proteasome inhibitor bortezomib (BOR), alone...

Full description

Bibliographic Details
Main Authors: María-Victoria Mateos, Enrique M. Ocio, Verónica González, Julio Dávila
Format: Article
Language:English
Published: European Medical Journal 2015-07-01
Series:European Medical Journal Hematology
Subjects:
Online Access:https://emj.emg-health.com/wp-content/uploads/sites/2/2018/02/RelapsedRefractory-Multiple-Myeloma-The-Current-State-of-Play1.pdf